The p73 polymorphisms are not associated with susceptibility to esophageal squamous cell carcinoma in a high incidence region of China

Diseases of the Esophagus

Volumn 20, Issue 4, 2007, Pages 290-296

  Ge, H ^a   Wang, Y M ^a   Cao, Y Y ^a   Chen, Z F ^a   Wen, D G ^a   Guo, W ^a   Wang, N ^a   Zhang, X F ^a   Li, Y ^a   Zhang, Jian Hui ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Esophageal squamous cell carcinoma; p73; Polymorphism; Susceptibility

Indexed keywords

ADENINE; GUANINE; PROTEIN P53; PROTEIN P73;

ADULT; APOPTOSIS; ARTICLE; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL CYCLE; CHINA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA REPAIR; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; EXON; FAMILY HISTORY; FEMALE; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN POLYMORPHISM; REGULATORY MECHANISM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RNA TRANSLATION; SMOKING; STATISTICAL SIGNIFICANCE; UPPER GASTROINTESTINAL TRACT;

CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHINA; DNA-BINDING PROTEINS; ESOPHAGEAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NUCLEAR PROTEINS; POLYMORPHISM, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 34447339918     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2007.00672.x     Document Type: Article

References (42)

1. Van Gijssel H E, Divi R L, Olivero O A et.al. Semiquantitation of polycyclic aromatic hydrocarbon-DNA adducts in human esophagus by immunohistochemistry and the automated cellular imaging system. Cancer Epidemiol Biomarkers Prev 2002; 11: 1622-9.
2. Guo W, Blot W J, Li J Y et.al. A nested case-control study of oesophageal and stomach cancers in the Linzhou nutrition intervention trial. Int J Epidemiol 1994; 23: 444-50.
3. Ji B T, Chow W H, Yang G et.al. The influence of cigarette smoking, alcohol and green tea consumption on the risk of carcinoma of the cardiac and distal stomach in Shanghai, China. Cancer 1996; 77: 2449-57.
4. Cai L, Yu S, Zhang Z. Helicobacter pylori infection and risk of gastric cancer in Changle County, Fujian Province, China. World J Gastroenterol 2000; 6: 374-6.
5. Matsha T, Erasmus R, Kafuko A B et.al. Oesophageal Cancer Research Group. Human papillomavirus associated with oesophageal cancer. J Clin Pathol 2002; 55: 587-90.
6. Zhang J, Schulz W A, Li Y et.al. Association of NAD (P)H: Quinone oxidoreductase 1 (NQO1)C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population. Carcinogenesis 2003; 24: 905-9.
7. Song C, Xing D, Tan W et.al. Methylenetet-rahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res 2001; 61: 3272-5.
8. Miao X, Xing D, Tan W et.al. Susceptibility to gastric cardia adenocarcinoma and genetic polymorphisms in methylenetet-rahydrofolate reductase in an at-risk Chinese population. Cancer Epidemiol Biomarkers Prev 2002; 11: 1454-8.
9. Tan W, Song N, Wang G Q et.al. Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1 and P1 on susceptibility to esophageal cancer among high-risk individuals in China. Cancer Epidemiol Biomarkers Prev 2000; 9: 551-6.
10. Zhang J, Cui Y, Kuang G et.al. Association of the thymidylate synthase polymorphisms with esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma. Carcinogenesis 2004; 25: 2479-85.
11. Kaghad M, Bonnet H, Yang A et.al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 1997; 90: 809-19.
12. Yang A, Walker N, Bronson R et.al. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 2000; 404: 99-103.
13. Flores E R, Tsai K Y, Crowley D et.al. p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature 2002; 416: 560-4.
14. Wang X Q, Ongkeko W M, Lau A W et.al. A possible role of p73 on the modulation of p53 level through MDM2. Cancer Res 2001; 61: 1598-603.
15. Weinberg R A. Oncogenes and tumor suppressor genes. CA Cancer J Clin 1994; 44: 160-70.
16. Mai M, Yokomizo A, Qian C et.al. Activation of p73 silent allele in lung cancer. Cancer Res 1998; 58: 2347-9.
17. Yokomizo A, Mai M, Tindall D J et.al. Overexpression of the wild type p73 gene in human bladder cancer. Oncogene 1998; 18: 1629-33.
18. Takahashi H, Ichimiya S, Nimura Y et.al. Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma. Cancer Res 1998; 58: 2076-7.
19. Ichimiya S, Nimura Y, Kageyama H et.al. p73 at chromosome 1p36.3 is lost in advanced atage neuroblastoma but its mutation is infrequent. Oncogene 1999; 18: 1061-6.
20. Nomoto S, Haruki N, Kondo M et.al. Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers. Cancer Res 1998; 58: 1380-3.
21. Cai Y C, Yang G Y, Nie Y et.al. Molecular alterations of p73 in hunan esophageal squamous cell carcinomas: Loss of heterozygosity occurs frequrntly; loss of imprinting and elevation of p73 expression may be related to defective p53. Carcinogenesis 2000; 21: 683-9.
22. Peters M A, Janer M, Kolb S et.al. Germline mutations in the p73 gene do not predispose to familial prostate-brain cancer. Prostate 2001; 48: 292-6.
23. Li Q, Athan E S, Wei M et.al. TP73 allelic expression in human brain and allele frequencies in Alzheimer's disease. BMC Med Genet 2004; 5: 14.
24. Hu Z, Miao X, Ma H et.al. Dinucleotide polymorphism of p73 gene is associated with a reduced risk of lung cancer in a Chinese population. Int J Cancer 2005; 114: 45-60.
25. Niwa Y, Hirose K, Matsuo K et.al. Association of p73 G4C14-to-A4T14 polymorphism at exon2 and p53 Arg72Pro polymorphism with the risk of endometrial cancer in Japanese subjects. Cancer Lett 2005; 219: 183-90.
26. Pfeifer D, Arbman G, Sun X F. Polymorphism of the p73 gene in relation to colorectal cancer risk and survival. Carcinogenesis 2005; 26: 103-7.
27. Hishida A, Matsuo K, Tajima K et.al. Polymorphisms of p53 Arg72Pro, p73G4C14-to-A4T14 at exon2 and p21 Ser31Arg and the risk of non-Hodgkin's lymphoma in Japanese. Leuk Lymphoma 2004; 45: 957-64.
28. Ryan B M, McManus R, Daly J S et.al. A common p73 polymorphism is associated with a reduced incidence of oesophageal carcinoma. Br J Cancer 2001; 85: 149-503.
29. Li G, Sturgis E M, Wang L et.al. Association of a p73 exon2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck. Carcinogenesis 2004; 25: 1911-16.
30. Li G, Wang L, Chamberlain R M et.al. p73 G4C14-to-A4T14 polymorphism and risk of Lung Cancer. Cancer Res 2004; 64: 6863-6.
31. Miller S A, Dybes D D, Polesky H F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acid Res 1988; 16: 1215.
32. Yang C S. Vitamin nutrition and gastroesophageal cancer. J Nutr 2000; 130: 338S-339S.
33. Yokokawa Y, Ohta S, Hou J et.al. Ecological study on the risks of esophageal cancer in Ci-Xian, China: The importance of nutritional status and the use of well water. Int J Cancer 1999; 83: 620-4.
34. Launoy G, Milan C H, Faivre J et.al. Alcohol, tobacco and oesophageal cancer: Effects of the duration of consumption, mean intake and current and former consumption. Br J Cancer 1997; 75: 1389-96.
35. Lavergne D, de Villiers E M. Papillomavirus in esophageal papillomas and carcinomas. Int J Cancer 1999; 80: 681-4.
36. Guo W, Wang N, Wang Y M et.al. Interleukin-10-1082 promoter polymorphism is not associated with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in a population of high-incidence region of north China. World J Gastroenterol 2005; 11: 858-62.
37. Li T, Lu Z M, Guo M et.al. p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China. Cancer 2002; 95: 2571-6.
38. Wu M T, Wu D C, Hsu H K et.al. Association between p21 codon 31 polymorphism and esophageal cancer risk in a Taiwanese population. Cancer Lett 2003; 25: 175-80.
39. Moll U M, Erster S, Zaika A et.al. p53, p63 and p73-solos. Alliances and feuds among family members. Biochim Biophys Acta 2001; 1552: 47-59.
40. Hiraki A, Matsuo K, Hamajima N et.al. Different risk relations with smoking for non-small-cell lung cancer: Comparison of TP53 and TP73 genotypes. Asian Pacific J Cancer Prev 2003; 4: 107-12.
41. Huang X E, Hamajima N, Katsuda N et.al. Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon2 genetic polymorphisms with the risk of Japanese breast cancer. Breast Cancer 2003; 10: 307-11.
42. Hamajima N, Matsuo K, Suzuki T et.al. No associations of p73 G4C14-to-A4T14 at exon2 and p53 Arg72Pro polymorphisms with the risk of digestive tract cancers in Japanese. Cancer Lett 2002; 181: 81-5.